elacestrant dihydrochloride

Italy

Drugs containing this active substance

  • ORSERDU

    This medicinal product is used to treat postmenopausal women and adult men with a specific type of advanced or metastatic breast cancer. It is indicated for estrogen receptor (ER)-positive and HER2-negative tumors in patients presenting ESR1 gene mutations who have not responded to other hormonal treatments.

    Form: tablets, film-coated

    Active substance Dosage
    elacestrant dihydrochloride -

    ATC: L02BA04

    Manufacturer: STEMLINE THERAPEUTICS BV